The dedication of Eli Lilly to comprehensive clinical trial programs has been crucial in addressing the FDAs rigorous safety standards, thus facilitating a promising treatment option for many individuals seeking assistance in weight management and diabetic care
Both drugs have shown promise for heart health, metabolic improvements, and even reducing the risk of certain chronic conditions
however, insulin remains essential for type 1 diabetes and advanced type 2 diabetes The choice between Mounjaro and established therapies should be individualised, considering factors such as baseline HbA1c, BMI, cardiovascular risk, renal function, patient preference for injection versus oral therapy, and local formulary guidance
There is no weakness in seeking this support
doi: 10.1128/CMR.17.4.840-862.2004 50 LiCLinXLinQLinYLinH